SpringWorks Therapeutics’ CEO, Saqib Islam, is set to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025. The announcement follows the company’s recent FDA approval of their first therapy, OGSIVEO®, marking a significant milestone in their mission to treat severe rare diseases and cancer.